T-Cell Engager-Armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy

被引：0
|
作者：
Yu, Feng [1 ]
Gottschalk, Stephen M. [1 ]
Song, Xiao-Tong [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
410
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [21] Treating pancreatic cancer with "armed" oncolytic adenoviruses and adoptive T-cell therapy
    Roach, Brett L.
    Yamamoto, Masato
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus
    Zhou, Danya
    Xu, Wei
    Ding, Xuping
    Guo, Haoran
    Wang, Jianyao
    Zhao, Guanghao
    Zhang, Chenglin
    Zhang, Zhongxian
    Wang, Zhimin
    Wang, Pengju
    Lu, Liming
    Yuan, Ming
    CANCER SCIENCE, 2024, 115 (04) : 1129 - 1140
  • [23] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment
    Nakamura, Takafumi
    CANCER SCIENCE, 2021, 112 : 579 - 579
  • [24] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment
    Nakatake, Motomu
    Kuwano, Nozomi
    Kaitsurumaru, Emi
    Kurosaki, Hajime
    Nakamura, Takafumi
    MOLECULAR THERAPY, 2021, 29 (05) : 1782 - 1793
  • [25] Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT)
    Zuo, Shuguang
    Wei, Min
    He, Bohao
    Chen, Anxian
    Wang, Shiqun
    Kong, Lingkai
    Zhang, Yenan
    Meng, Gang
    Xu, Tiancheng
    Wu, Jingyi
    Yang, Fuming
    Zhang, Hailin
    Wang, Shibing
    Guo, Ciliang
    Wu, Junhua
    Dong, Jie
    Wei, Jiwu
    EBIOMEDICINE, 2021, 64
  • [26] Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
    Ma, Jing
    Jin, Chuan
    Cancer, Matko
    Wang, Hai
    Ramachandran, Mohanraj
    Yu, Di
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 : 356 - 366
  • [27] Combining Oncolytic Vaccinia Virotherapy with Adoptive T Cell Therapy
    Ngo, Minhtran Charlotte
    Ando, Jun
    Leen, Ann M.
    Breitbach, Caroline
    Moon, Anne
    Kirn, David
    Bell, John
    Rooney, Cliona M.
    BLOOD, 2011, 118 (21) : 1726 - 1727
  • [28] IL-2-armed oncolytic vaccinia virus exerts potent antitumor effects in human pancreatic cancer
    Wang, R.
    Feist, M.
    Guo, Z.
    Felsenstein, M.
    Reutzel-Selke, A.
    Pratschke, J.
    Sauer, I. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1434 - S1434
  • [29] Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
    Zhu, Haoran
    Zhang, Wanrong
    Guo, Qingguo
    Fan, Ruoyue
    Luo, Guangzuo
    Liu, Ying
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [30] Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
    Nandakumar Packiriswamy
    Deepak Upreti
    Yumei Zhou
    Rehan Khan
    Amber Miller
    Rosa M. Diaz
    Cliona M. Rooney
    Angela Dispenzieri
    Kah-Whye Peng
    Stephen J. Russell
    Leukemia, 2020, 34 : 3310 - 3322
12345